Tonix Pharmaceuticals Holding Corp (TNXP)

[Viewmont]

'PATENT $TNXP Tonix Pharmaceuticals received a Notice of Allowance on 2/1 from the US Patent and Trademark Office for Application No. 16/518,338, titled: EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE.' - PatentEagle
2:31 pm ET February 3, 2021 (Benzinga) Print
https://twitter.com/PatentEagle/status/1357048846933757961

Tonix Pharmaceuticals CEO Believes That Additional COVID-19 Vaccine Research Is Still Needed
https://finance.yahoo.com/news/tonix-pharmaceuticals-ceo-believes-additional-135127182.html

10:41 am ET
Tonix Pharmaceuticals Shares Quiet; Co Tweets 'At the recent @Benzinga Global Small Cap Conference, Dr. Seth Lederman, CEO discussed $TNXP's two #COVID19 #vaccines being developed for long-term #immunity, the importance of having multiple vaccine options'
Benzinga

https://icrinc.touchcast.com/showtime/icr-conference/embed/8299b274-ad5e-40cd-1969-cae34931c5f0


https://content.equisolve.net/_d68b8f80e836ce2305ff8b1d49e67460/tonixpharma/db/114/2750/video/Jessica+Morris+-+Tonix+Webinar+%281%29.mp4

https://www.tonixpharma.com/therapeutic-areas/coronavirus-disease-2019-covid-19

https://www.tonixpharma.com/

Share Structure
Market Cap Market Cap
318,697,196
02/03/2021
Authorized Shares
400,000,000
02/02/2021
Outstanding Shares
265,580,997
02/02/2021
Restricted
2,003,314
02/02/2021
Unrestricted
263,577,683
02/02/2021
Held at DTC
263,535,847
02/02/2021
Float
Not Available